Atlas Trials

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT00030446 · COMPLETED

Trial details

NCT number
NCT00030446
Sponsor
NCIC Clinical Trials Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Start date
2002-01-10
Primary completion
2005-02-11
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.